Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
American Journal of Hematology
|
November 8, 2025
Strategies to Enhance CAR-T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization
Mengqi Yu, Tingting Yang, Shuyi Ding, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|
September 26, 2022
Risk factors of acute kidney injury during BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Yuqi Lyu, Mingming Zhang, Guoqing Wei, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 6, 2022
Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study
Shuyi Ding, Lingxia Cai, Aiyun Jin, et al.
Journal of Medical Economics
|
May 5, 2023
Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China
Weijia Wu, Shuyi Ding, Zhang Mingming, et al.
Asia-Pacific Journal of Oncology Nursing
|
October 2, 2025
Symptom clusters and sentinel symptoms during post-transplant recovery in recipients of allogeneic hematopoietic stem cell transplantation: A cross-sectional study
Ping Xu, Shuyi Ding, Li Zheng, et al.
British Journal of Cancer
|
November 2, 2025
Compound staphylococcal lysostaphin for oral mucositis prophylaxis in hematopoietic stem cell transplantation recipients: a non-inferiority randomized trial
Xiaoyu Zhou, Zhengwen Pan, Weiwei Zhou, et al.
European Journal of Haematology
|
September 12, 2023
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancy
Liu Chen, Shuyi Ding, Yin Cheng, et al.
BMC Cancer
|
November 3, 2023
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
Shuyi Ding, Rongrong Chen, Linqin Wang, et al.
Optics Express
|
June 11, 2026
Gate-tunable bipolar transport in PbSe/GeSe/MoS<sub>2</sub> heterojunction photodetector array for medication optical rotation detection
Haibo Zhang, Hanqing Wu, Yang Shen, et al.
Frontiers in Oncology
|
July 19, 2021
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Linqin Wang, Ruimin Hong, Linghui Zhou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
American Journal of Hematology
|
November 8, 2025
Strategies to Enhance CAR-T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization
Mengqi Yu, Tingting Yang, Shuyi Ding, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|
September 26, 2022
Risk factors of acute kidney injury during BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Yuqi Lyu, Mingming Zhang, Guoqing Wei, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 6, 2022
Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study
Shuyi Ding, Lingxia Cai, Aiyun Jin, et al.
Journal of Medical Economics
|
May 5, 2023
Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China
Weijia Wu, Shuyi Ding, Zhang Mingming, et al.
Asia-Pacific Journal of Oncology Nursing
|
October 2, 2025
Symptom clusters and sentinel symptoms during post-transplant recovery in recipients of allogeneic hematopoietic stem cell transplantation: A cross-sectional study
Ping Xu, Shuyi Ding, Li Zheng, et al.
British Journal of Cancer
|
November 2, 2025
Compound staphylococcal lysostaphin for oral mucositis prophylaxis in hematopoietic stem cell transplantation recipients: a non-inferiority randomized trial
Xiaoyu Zhou, Zhengwen Pan, Weiwei Zhou, et al.
European Journal of Haematology
|
September 12, 2023
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancy
Liu Chen, Shuyi Ding, Yin Cheng, et al.
BMC Cancer
|
November 3, 2023
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
Shuyi Ding, Rongrong Chen, Linqin Wang, et al.
Optics Express
|
June 11, 2026
Gate-tunable bipolar transport in PbSe/GeSe/MoS<sub>2</sub> heterojunction photodetector array for medication optical rotation detection
Haibo Zhang, Hanqing Wu, Yang Shen, et al.
Frontiers in Oncology
|
July 19, 2021
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Linqin Wang, Ruimin Hong, Linghui Zhou, et al.
Page
of 2